Pacific Edge’s American dream

Pacific Edge’s American dream
The US Affordable Care Act can be tricky to navigate. (Image: Getty)
Paul McBeth
Pacific Edge has long wanted to crack the United States market, which it has seen for a long time as validating the hundreds of millions spent in developing its Cxbladder non-invasive cancer detection tool. More than 20 years since listing, after it was spun out of University of Otago research, the company has raised $297.23 million selling shares and convertible preference shares and as people exercised options to fund accumulated losses of $216.8m and counting. That’s not going to change any time soon after the company crashed...

More Markets

NZ sharemarket down 0.2% as Trump retakes office
Markets Market Close

NZ sharemarket down 0.2% as Trump retakes office

The S&P/NZX 50 Index closed at 13.052.9, down 35.41 points or 0.27%.

Graham Skellern 21 Jan 2025
Rua Bioscience psilocybin study targets meth addiction
Markets

Rua Bioscience psilocybin study targets meth addiction

The ‘preparation step’ will be followed by an ‘experiential session’ with the mushroom.

Gregor Thompson 21 Jan 2025
Jarden sees Mercury, Genesis upside
Markets

Jarden sees Mercury, Genesis upside

Energy margin data points to earnings upgrades for both gen-tailers.

Pattrick Smellie 21 Jan 2025
Cooks Coffee continues strong sales growth
Retail

Cooks Coffee continues strong sales growth

The sales growth comes at a time of rapid expansion for the firm.

Staff reporters 21 Jan 2025